The Impact of Upcoming Treatments in Huntington’s Disease: Resource Capacity Limitations and Access to Care Implications

BACKGROUND: The most advanced disease-modifying therapies (DMTs) in development for Huntington’s disease (HD) require intrathecal (IT) administration, which may create or exacerbate bottlenecks in resource capacity. OBJECTIVE: To understand the readiness of healthcare systems for intrathecally admin...

Descripción completa

Detalles Bibliográficos
Autores principales: Guttman, Mark, Pedrazzoli, Marco, Ponomareva, Marina, Pelletier, Marsha, Townson, Louisa, Mukelabai, Kopano, Levine, Aaron, Nordström, Anna-Lena, Reilmann, Ralf, Burgunder, Jean-Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2021
Materias:
Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8293639/
https://www.ncbi.nlm.nih.gov/pubmed/33843690
http://dx.doi.org/10.3233/JHD-200462

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8293639/
https://www.ncbi.nlm.nih.gov/pubmed/33843690
http://dx.doi.org/10.3233/JHD-200462

Ejemplares similares